PEGylated Proteins Market Set to Reach USD 19.1 Billion by 2031, Driven by Advancements in Drug Delivery: - Market Research Intellect [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
diseases such as cancer, hepatitis, and rheumatoid arthritis. PEGylation enhances the stability, solubility, and half-life of therapeutic proteins, leading to better efficacy and fewer side effects. Additionally, advancements in biologics and increasing R&D investments in biotechnology and pharmaceuticals are fueling market growth. The rise in chronic disease prevalence and the need for advanced treatment options further boost the adoption of PEGylated proteins. LEWES, Del. Nov. 14, 2024 /PRNewswire/ -- The PEGylated Proteins Market is projected to grow from approximately USD 12.3 billion in 2024 to USD 19.1 billion by 2031, with a compound annual growth rate (CAGR) of around 6.5%. This growth is driven by the increasing use of PEGylated proteins in drug delivery, particularly for treating chronic diseases such as cancer and rheumatoid arthritis, as well as rising investments in biotechnology and pharmaceuticals. Download PDF Brochure: https://www.marketresearchintellect.com/downl
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary [CNN]CNN
- Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary [CNN]CNN
- Vivo, OmniScience's genAI-powered clinical trial control tower, wins 2024 The Whale Tank competition at Innovation Network GatheringPR Web
- Pneumonia Vaccine Market Poised for Significant Expansion: Projected to Achieve $28 Billion by 2031 with a Robust 7.2% CAGR - Market Research Intellect [Yahoo! Finance]Yahoo! Finance
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare ConferenceBusiness Wire
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 11/4/24 - Form 10-Q
- 11/1/24 - Form 4
- 11/1/24 - Form 4
- PFE's page on the SEC website